Page 1
Migraine Headache
Binder WJ, Brin MF, Blitzer A, et al.
Botulinum toxin type A (BOTOX) for treatment of migraine
headaches: An open-label study. Otolaryngology-Head and Neck
Surgery 2000;123(6):669-76.
Brin MF, Swope DM, O’Brien C, Abbasi S,
Pogoda JM. BOTOX® for migraine: double-blind, placebo-controlled
region-specific evaluation. Cephalalgia 2000;20(4):421-422.
Klapper JA, Klapper A. Use of botulinum
toxin in chronic daily headaches associated with migraine.
Headache Q 1999 Jul;10(2): 141-3.
Mauskop A, Basdeo R. Botulinum toxin A in a
effective prophylactic therapy for migraines. Cephalalgia
2000;20(4): 422.
Silberstein S, Mathew N, et al. Botulinum
Toxin Type A as a Migraine Preventive Treatment. Headache
2000;40:445-450.
Silberstein,SD. Review of botulinum toxin
type A and its clinical applications in migraine headache.
Expert Opin. Pharmacother. (2001) 2(10):1649-1654
Smuts JA, Barnard PWA. Botulinum toxin type
A in the treatment of headache syndromes: a clinical report on
79 patients. Cephalalgia 2000;20(4):332.
Troost, BT: Botulinum Toxin Type A
(BOTOX®) for Intractable Headache. AHS Annual Meeting,
Seattle, June 22, 2002, Poster S137 (On-Line) (large .pdf
file )
Troost
BT, Rosenberg JR, Wiles R. Improvement in Intractable Headache with Repeated
Botulinum Toxin Type Treatment. Neurology 2003;60(5)[Suppl. 1]:A323.
Troost,
BT. Botulinum Toxin
Type A (BoNT-A) in the Treatment of Migraine and Other
Headaches. Expert
Rev Neurotherapeutics 2004:4(1): 27-31.
Troost
BT. Botulinum Toxin Type A (BoNT-A)
in the Management of Headache: A
Review of the Literature and Personal Experience.
J Headache and Pain. 2004;
5:15
-22.
Sinclair
M, David R, Wiles R, Troost BT. Band, Patch and Halo Injection Patterns for
Headache with BoNT- A. Presented at 46th Annual
Scientific Meeting of the American Headache Society, Vancouver, BC,
Canada. June 11, 2004.
(Poster ON-Line .pdf file )
Go to Bibliography Page 2:
Chronic Tension & Chronic Daily Headache
|
